Table of Contents
Journal of Biophysics
Volume 2017, Article ID 1059216, 12 pages
https://doi.org/10.1155/2017/1059216
Research Article

Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study

1Postgraduate Institute of Science, University of Peradeniya, 20400 Peradeniya, Sri Lanka
2Department of Chemistry, University of Peradeniya, 20400 Peradeniya, Sri Lanka

Correspondence should be addressed to R. J. K. U. Ranatunga; kl.ca.ndp@agnutanarydu

Received 28 October 2016; Accepted 15 January 2017; Published 21 February 2017

Academic Editor: Jianwei Shuai

Copyright © 2017 P. V. G. M. Rathnayake et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Borna, S. Imani, M. Iman, and S. Azimzadeh Jamalkandi, “Therapeutic face of RNAi: in vivo challenges,” Expert Opinion on Biological Therapy, vol. 15, no. 2, pp. 269–285, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Tabernero, G. I. Shapiro, P. M. LoRusso et al., “First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement,” Cancer Discovery, vol. 3, no. 4, pp. 406–417, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. L. Davidson and P. B. McCray, “Current prospects for RNA interference-based therapies,” Nature Reviews Genetics, vol. 12, no. 5, pp. 329–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Aagaard and J. J. Rossi, “RNAi therapeutics: principles, prospects and challenges,” Advanced Drug Delivery Reviews, vol. 59, no. 2-3, pp. 75–86, 2007. View at Publisher · View at Google Scholar
  5. D. Cejka, D. Losert, and V. Wacheck, “Short interfering RNA (siRNA): tool or therapeutic?” Clinical Science, vol. 110, no. 1, pp. 47–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Luchnik, “DNA conformational transitions induced by supercoiling control transcription in chromatin,” Gene Regulation and Systems Biology, vol. 8, pp. 89–96, 2014. View at Publisher · View at Google Scholar
  7. H. Yin, R. L. Kanasty, A. A. Eltoukhy, A. J. Vegas, J. R. Dorkin, and D. G. Anderson, “Non-viral vectors for gene-based therapy,” Nature Reviews Genetics, vol. 15, no. 8, pp. 541–555, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. P. D. Zamore, “RNA interference: listening to the sound of silence,” Nature Structural Biology, vol. 8, no. 9, pp. 746–750, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Foerg and H. P. Merkle, “On the biomedical promise of cell penetrating peptides: limits versus prospects,” Journal of Pharmaceutical Sciences, vol. 97, no. 1, pp. 144–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-L. Yang, W.-T. Chang, and Y.-W. Shih, “Gene therapy using RNAi,” in Gene Therapy-Developments and Future Perspectives, InTech, Rijeka, Croatia, 2011. View at Publisher · View at Google Scholar
  11. S. Trabulo, A. L. Cardoso, M. Mano, and M. C. P. de Lima, “Cell-penetrating peptides—mechanisms of cellular uptake and generation of delivery systems,” Pharmaceuticals, vol. 3, no. 4, pp. 961–993, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Lehto, K. Kurrikoff, and Ü. Langel, “Cell-penetrating peptides for the delivery of nucleic acids,” Expert Opinion on Drug Delivery, vol. 9, no. 7, pp. 823–836, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. I. R. de Figueiredo, J. M. Freire, L. Flores, A. S. Veiga, and M. A. R. B. Castanho, “Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies,” IUBMB Life, vol. 66, no. 3, pp. 182–194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. N. Karunaratne, M. Jafari, R. J. K. U. Ranatunga, and A. Siriwardhana, “Natural carriers for siRNA delivery,” Current Pharmaceutical Design, vol. 21, no. 31, pp. 4529–4540, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Neumann, M. Schaefer-Ridder, Y. Wang, and P. H. Hofschneider, “Gene transfer into mouse lyoma cells by electroporation in high electric fields,” EMBO Journal, vol. 1, no. 7, pp. 841–845, 1982. View at Google Scholar · View at Scopus
  16. A. Akinc, A. Zumbuehl, M. Goldberg et al., “A combinatorial library of lipid-like materials for delivery of RNAi therapeutics,” Nature Biotechnology, vol. 26, no. 5, pp. 561–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Foged and H. M. Nielsen, “Cell-penetrating peptides for drug delivery across membrane barriers,” Expert Opinion on Drug Delivery, vol. 5, no. 1, pp. 105–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Mussbach, M. Franke, A. Zoch, B. Schaefer, and S. Reissmann, “Transduction of peptides and proteins into live cells by cell penetrating peptides,” Journal of Cellular Biochemistry, vol. 112, no. 12, pp. 3824–3833, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Freire, A. S. Veiga, I. Rego de Figueiredo et al., “Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action,” The FEBS Journal, vol. 281, no. 1, pp. 191–215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Watanabe, M. Harada-Shiba, A. Suzuki et al., “In vivo siRNA delivery with dendritic poly(l-lysine) for the treatment of hypercholesterolemia,” Molecular BioSystems, vol. 5, no. 11, pp. 1306–1310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. W. S. Kam, Z. Liu, and H. Dai, “Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing,” Journal of the American Chemical Society, vol. 127, no. 36, pp. 12492–12493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Akinc, W. Querbes, S. De et al., “Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms,” Molecular Therapy, vol. 18, no. 7, pp. 1357–1364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Saraswathy and S. Gong, “Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment,” Materials Today, vol. 17, no. 6, pp. 298–306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. E. R. Gillies and J. M. J. Fréchet, “Dendrimers and dendritic polymers in drug delivery,” Drug Discovery Today, vol. 10, no. 1, pp. 35–43, 2005. View at Publisher · View at Google Scholar
  25. A. D. Frankel and C. O. Pabo, “Cellular uptake of the tat protein from human immunodeficiency virus,” Cell, vol. 55, no. 6, pp. 1189–1193, 1988. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Reissmann, “Cell penetration: scope and limitations by the application of cell-penetrating peptides,” Journal of Peptide Science, vol. 20, no. 10, pp. 760–784, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Xiong and M. Sundaralingam, “Protein–nucleic acid interaction: major groove recognition determinants,” in Encyclopedia of Life Sciences, John Wiley & Sons Ltd, Chichester, UK, 2001. View at Publisher · View at Google Scholar
  28. R. Schleif, “DNA binding by proteins,” Science, vol. 241, no. 4870, pp. 1182–1187, 1988. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Ryter and S. C. Schultz, “Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA,” The EMBO Journal, vol. 17, no. 24, pp. 7505–7513, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-M. Crowet, L. Lins, S. Deshayes et al., “Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo,” Biochimica et Biophysica Acta—Biomembranes, vol. 1828, no. 2, pp. 499–509, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Fohrer, M. Hennig, and T. Carlomagno, “Influence of the 2′-hydroxyl group conformation on the stability of A-form helices in RNA,” Journal of Molecular Biology, vol. 356, no. 2, pp. 280–287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. El Andaloussi, T. Lehto, I. Mäger et al., “Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo,” Nucleic Acids Research, vol. 39, no. 9, pp. 3972–3987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Lundberg, S. El-Andaloussi, T. Sütlü, H. Johansson, and Ü. Langel, “Delivery of short interfering RNA using endosomolytic cell-penetrating peptides,” The FASEB Journal, vol. 21, no. 11, pp. 2664–2671, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Padari, K. Koppel, A. Lorents et al., “S413-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells,” Bioconjugate Chemistry, vol. 21, no. 4, pp. 774–783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Thomas and A. Macke David, “Molecular modeling of nucleic acids,” in ACS Symposium Series, NB. Leontis and J. SantaLucia, Eds., vol. 682, American Chemical Society, Washington, DC, USA, 1997. View at Google Scholar
  36. Y. Shen, J. Maupetit, P. Derreumaux, and P. Tufféry, “Improved PEP-FOLD approach for peptide and miniprotein structure prediction,” Journal of Chemical Theory and Computation, vol. 10, no. 10, pp. 4745–4758, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Maupetit, P. Derreumaux, and P. Tuffery, “PEP-FOLD: an online resource for de novo peptide structure prediction,” Nucleic Acids Research, vol. 37, no. 2, pp. W498–W503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Maupetit, P. Derreumaux, and P. Tufféry, “A fast method for large-scale de novo peptide and miniprotein structure prediction,” Journal of Computational Chemistry, vol. 31, no. 4, pp. 726–738, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. C. Phillips, R. Braun, W. Wang et al., “Scalable molecular dynamics with NAMD,” Journal of Computational Chemistry, vol. 26, no. 16, pp. 1781–1802, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. R. Comeau, D. W. Gatchell, S. Vajda, and C. J. Camacho, “ClusPro: a fully automated algorithm for protein-protein docking,” Nucleic Acids Research, vol. 32, supplement 2, pp. W96–W99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. S. R. Comeau, D. W. Gatchell, S. Vajda, and C. J. Camacho, “ClusPro: an automated docking and discrimination method for the prediction of protein complexes,” Bioinformatics, vol. 20, no. 1, pp. 45–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. H. J. C. Berendsen, D. van der Spoel, and R. van Drunen, “GROMACS: a message-passing parallel molecular dynamics implementation,” Computer Physics Communications, vol. 91, no. 1–3, pp. 43–56, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Vanommeslaeghe, E. Hatcher, C. Acharya et al., “CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields,” Journal of Computational Chemistry, vol. 31, no. 4, pp. 671–690, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Joliot, C. Pernelle, H. Deagostini-Bazin, and A. Prochiantz, “Antennapedia homeobox peptide regulates neural morphogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 5, pp. 1864–1868, 1991. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Derossi, A. H. Joliot, G. Chassaing, and A. Prochiantz, “The third helix of the Antennapedia homeodomain translocates through biological membranes,” Journal of Biological Chemistry, vol. 269, no. 14, pp. 10444–10450, 1994. View at Google Scholar · View at Scopus
  46. E. Vivès, P. Brodin, and B. Lebleu, “A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus,” The Journal of Biological Chemistry, vol. 272, no. 25, pp. 16010–16017, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. I. A. Ignatovich, E. B. Dizhe, A. V. Pavlotskaya et al., “Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 tat protein are transferred to mammalian cells by endocytosis-mediated pathways,” Journal of Biological Chemistry, vol. 278, no. 43, pp. 42625–42636, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Futaki, T. Suzuki, W. Ohashi et al., “Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery,” Journal of Biological Chemistry, vol. 276, no. 8, pp. 5836–5840, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Nakase, T. Takeuchi, G. Tanaka, and S. Futaki, “Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides,” Advanced Drug Delivery Reviews, vol. 60, no. 4-5, pp. 598–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Tan and A. D. Frankel, “Structural variety of arginine-rich RNA-binding peptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 12, pp. 5282–5286, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Futaki, “Membrane-permeable arginine-rich peptides and the translocation mechanisms,” Advanced Drug Delivery Reviews, vol. 57, no. 4, pp. 547–558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Pooga, M. Hällbrink, M. Zorko, and Ü. Langel, “Cell penetration by transportan,” The FASEB Journal, vol. 12, no. 1, pp. 67–77, 1998. View at Google Scholar · View at Scopus
  53. A. Elmquist, M. Lindgren, T. Bartfai, and Ü. Langel, “Ve-cadherin-derived cell-penetrating peptide, pVEC with carrier functions,” Experimental Cell Research, vol. 269, no. 2, pp. 237–244, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Elmquist, M. Hansen, and Ü. Langel, “Structure–activity relationship study of the cell-penetrating peptide pVECde pVEC,” Biochimica et Biophysica Acta—Biomembranes, vol. 1758, no. 6, pp. 721–729, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. I. O. Akdag and E. Ozkirimli, “The uptake mechanism of the cell-penetrating pVEC peptide,” Journal of Chemistry, vol. 2013, Article ID 851915, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Elmquist and Ü. Langel, “In vitro uptake and stability study of pVEC and its all-D analog,” Biological Chemistry, vol. 384, no. 3, pp. 387–393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. M. C. Morris, P. Vidal, L. Chaloin, F. Heitz, and G. Divita, “A new peptide vector for efficient delivery of oligonucleotides into mammalian cells,” Nucleic Acids Research, vol. 25, no. 14, pp. 2730–2736, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Crombez, M. C. Morris, S. Dufort et al., “Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth,” Nucleic Acids Research, vol. 37, no. 14, pp. 4559–4569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Palm-Apergi, A. Lorents, K. Padari, M. Pooga, and M. Hällbrink, “The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake,” The FASEB Journal, vol. 23, no. 1, pp. 214–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Crombez, G. Aldrian-Herrada, K. Konate et al., “A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells,” Molecular Therapy, vol. 17, no. 1, pp. 95–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Hoyer, U. Schatzschneider, M. Schulz-Siegmund, and I. Neundorf, “Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery,” Beilstein Journal of Organic Chemistry, vol. 8, pp. 1788–1797, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Jafari, D. N. Karunaratne, C. M. Sweeting, and P. Chen, “Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency,” Biochemistry, vol. 52, no. 20, pp. 3428–3435, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. C. J. Wrighton, “Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B,” Journal of Experimental Medicine, vol. 183, no. 3, pp. 1013–1022, 1996. View at Publisher · View at Google Scholar
  64. X.-Y. Liu, S. Timmons, Y.-Z. Lin, and J. Hawiger, “Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 11819–11824, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Zhang, T. R. Torgerson, X.-Y. Liu et al., “Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9184–9189, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Bleifuss, T. Kammertoens, A. Hutloff et al., “The translocation motif of hepatitis B virus improves protein vaccination,” Cellular and Molecular Life Sciences, vol. 63, no. 5, pp. 627–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Rojas, J. P. Donahue, Z. Tan, and Y.-Z. Lin, “Genetic engineering of proteins with cell membrane permeability,” Nature Biotechnology, vol. 16, no. 4, pp. 370–375, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. M. C. Morris, L. Chaloin, J. Méry, F. Heitz, and G. Divita, “A novel potent strategy for gene delivery using a single peptide vector as a carrier,” Nucleic Acids Research, vol. 27, no. 17, pp. 3510–3517, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Rhee and P. Davis, “Mechanism of uptake of C105Y, a novel cell-penetrating peptide,” Journal of Biological Chemistry, vol. 281, no. 2, pp. 1233–1240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Kozakov, R. Brenke, S. R. Comeau, and S. Vajda, “PIPER: an FFT-based protein docking program with pairwise potentials,” Proteins: Structure, Function, and Bioinformatics, vol. 65, no. 2, pp. 392–406, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Pauling, R. B. Corey, and H. R. Branson, “The structure of proteins; two hydrogen-bonded helical configurations of the polypeptide chain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 37, no. 4, pp. 205–211, 1951. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Eiríksdóttir, K. Konate, Ü. Langel, G. Divita, and S. Deshayes, “Secondary structure of cell-penetrating peptides controls membrane interaction and insertion,” Biochimica et Biophysica Acta - Biomembranes, vol. 1798, no. 6, pp. 1119–1128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Madani, S. Lindberg, Ü. Langel, A. Gräslund, and S. Futaki, “Mechanisms of cellular uptake of cell-penetrating peptides,” Journal of Biophysics, vol. 2011, Article ID 414729, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus